Open AccessPathological complete response to neoadjuvant trastuzumab and pertuzumab therapy is related to human epidermal growth factor receptor 2 (HER2) amplification level in HER2-amplified breast cancer
Author(s) -
Jin Hyuk Choi,
Chang Wan Jeon,
Young Ok Kim,
Sung Ui Jung
Publication year - 2020
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000023053
Subject(s) - pertuzumab , trastuzumab , medicine , breast cancer , oncology , docetaxel , lapatinib , neoadjuvant therapy , cancer